Single-Molecule Real-Time Sequencing for MUC1 VNTR Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis
BACKGROUND: ADTKD-MUC1 is caused by frameshift mutations in the MUC1 gene, producing a frameshifted neoprotein (MUC1fs) toxic to kidney cells. The gene's variable number of tandem repeats (VNTR), with ∼80% guanine/cytosine content, has made it largely inaccessible to standard short-read sequencing, leaving the reference sequence and natural variation poorly defined and complicating mutation detection. METHODS: Using Single Molecule, Real-Time (SMRT) sequencing, we characterized MUC1 VNTR in 300 individuals, including 279 from 143 families suspected of having ADTKD-MUC1, assessing VNTR length, repeat structure, and frameshift mutations. Results were compared with the CLIA-approved probe-extension assay, detecting the prevalent 59dupC mutation, and with MUC1fs immunohistochemistry, which detects the pathogenic protein independent of the underlying genomic change. RESULTS: We identified 215 unique VNTR alleles composed of 80 distinct repeat units, 46 (58%) of which were novel, and nine distinct frameshift mutations present on 52 mutated alleles. Overall, MUC1 frameshift mutations were identified in 71 of 143 families (50%) with suspected ADTKD-MUC1, comprising 135 affected individuals (48%). The SMRT assay outperformed the probe-extension assay by identifying frameshift mutations in two families with previously inconclusive results and in eight additional families whose mutations were undetectable by the probe-extension design. When successful, SMRT assay showed 100% concordance with probe-extension assay at the family level and 98% at the individual level, with discordance attributable to allelic dropout inherent to long-read sequencing. Analysis of the mutational spectrum confirmed 59dupC as the most prevalent mutation, affecting ∼90% of families, while the other eight mutation types occurred at most twice. CONCLUSIONS: The SMRT assay outperformed the CLIA-approved probe-extension assay by detecting essentially all VNTR-associated frameshift mutations. The probe-extension assay identified ∼90% of affected families. MUC1fs immunohistochemistry added diagnostic value in genetically unresolved cases by detecting the pathogenic protein independent of the underlying mutation.
Authors
- Jana Sovová
- Omri Teltsh (ORCID: https://orcid.org/0000-0003-3422-809X)
- C. C. Deltas
- Martina Živná (ORCID: https://orcid.org/0000-0003-1968-824X)
- Hana Hartmannová (ORCID: https://orcid.org/0000-0001-7787-832X)
- Alena Vrbacká
- Viktor Stránecký (ORCID: https://orcid.org/0000-0002-2599-6479)
- Brendan Blumenstiel
- Silvie Rajnochová-Bloudíčková (ORCID: https://orcid.org/0000-0003-0270-571X)
- Lenka Mrázová (ORCID: https://orcid.org/0000-0003-4347-7768)
- Romana Ryšavá (ORCID: https://orcid.org/0000-0002-4162-128X)
- Kendrah Kidd (ORCID: https://orcid.org/0000-0003-3771-0949)
- Anna Přistoupilová (ORCID: https://orcid.org/0000-0003-0047-9405)
- Petr Vyleťal (ORCID: https://orcid.org/0000-0002-9357-1237)
- Tereza Kmochová (ORCID: https://orcid.org/0009-0001-6677-7029)
- Christoforos Stavrou
- Václav Janoušek (ORCID: https://orcid.org/0000-0002-6894-6826)
- Helena Trešlová (ORCID: https://orcid.org/0000-0003-0180-1179)
- Gregory Papagregoriou (ORCID: https://orcid.org/0000-0002-2440-9789)
- Gianpiero L. Cavalleri (ORCID: https://orcid.org/0000-0002-9802-0506)
- Kateřina Hodaňová (ORCID: https://orcid.org/0000-0001-9172-9945)
- Martin Radina (ORCID: https://orcid.org/0009-0001-0027-8665)
- Dita Mušálková (ORCID: https://orcid.org/0000-0003-4795-3960)
- Anthony J. Bleyer (ORCID: https://orcid.org/0000-0002-2804-5273)
- Peter J. Conlon (ORCID: https://orcid.org/0000-0001-6772-9531)
- Diana M. Toledo (ORCID: https://orcid.org/0000-0002-7501-8286)
- Michelle Clince
- Matthew DeFelice (ORCID: https://orcid.org/0009-0007-2481-8842)
- Stanislav Kmoch (ORCID: https://orcid.org/0000-0002-6239-707X)
- Veronika Barešová (ORCID: https://orcid.org/0000-0001-8989-6090)
- O. Viklicky
- Ibrahim Bitar (ORCID: https://orcid.org/0000-0002-9117-3729)
- Klára Svojšová
- Heidi A. Bleyer
- Antonio Güemes Sánchez (ORCID: https://orcid.org/0009-0005-9852-0868)
- Lauren Martin (ORCID: https://orcid.org/0009-0003-6450-5411)
- Sofía Jorge
- Colm Rowan
- Innet Lajtmanov
- J. Revez Lopes
- Marina Distefano
- Elhussein Elhassan
- Abby Taylor
Institutions
- Broad Institute (US)
- Royal College of Surgeons in Ireland (IE)
- Charles University (CZ)
- Beaumont Hospital (IE)
- University of Cyprus (CY)
- Institute of Clinical and Experimental Medicine (CZ)
- B. Braun (Czechia) (CZ)
- Hospital de Santa Maria (PT)
- General University Hospital in Prague (CZ)
- Wake Forest University (US)
Publication Details
- Journal
- Journal of the American Society of Nephrology
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1681/asn.0000001103
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00